0001437749-17-004495.txt : 20170414 0001437749-17-004495.hdr.sgml : 20170414 20170314153249 ACCESSION NUMBER: 0001437749-17-004495 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIVEVE MEDICAL, INC. CENTRAL INDEX KEY: 0000879682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043153858 STATE OF INCORPORATION: B0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085301900 MAIL ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 FORMER COMPANY: FORMER CONFORMED NAME: PLC SYSTEMS INC DATE OF NAME CHANGE: 19930328 CORRESP 1 filename1.htm vive20170314_corresp.htm

Cowen and Company, LLC
599 Lexington Avenue

New York, NY 10022

 

 

 

 

March 14, 2017

 

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:     Amanda Ravitz, Assistant Director

 

Re:

Viveve Medical, Inc.
Acceleration Request for Registration Statement on Form S-1
File No. 333-216187

 

Dear Ms. Ravitz:

 

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, the representative of the several underwriters (the “Representative”), hereby join in the request of Viveve Medical, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on March 16, 2017 or as soon thereafter as practicable.

 

Pursuant to Rule 460 under the Act, please be advised that we expect to distribute approximately 477 copies of the Preliminary Prospectus dated March 13, 2017 (the “Preliminary Prospectus”) to underwriters, dealers, institutions and others.

 

In connection with the Preliminary Prospectus distribution for the above-referenced issue, the undersigned, as the Representative of the underwriters, has confirmed that they have complied with and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

 

[Signature page follows]

 

 
 
 

 

Cowen and Company, LLC
As Representative of the several Underwriters

 

 

By: Cowen and Company, LLC

 

 

By: /s/ Rob Weir                                       
Name: Rob Weir                                             
Title: Managing Director                          

 

 

 

 

 

 

 

 

[Signature page to Acceleration Request]